患者优先:年轻成人急性淋巴细胞白血病中门冬酰胺酶治疗的管理
本继续医学教育课程整合真实患者故事、当前证据、不断更新的指南推荐和专家临床经验,为血液/肿瘤科医生提供年轻成人急性淋巴细胞白血病(ALL)中门冬酰胺酶治疗的实用策略。课程以病例为基础,提供门冬酰胺酶相关毒性减轻、监测和管理指导,并涉及系统层面和心理社会障碍。
要点
- 推荐进行治疗性药物监测门冬酰胺酶活性,并识别临床和沉默性过敏反应。
- 免疫介导失活后,应及时将大肠杆菌来源门冬酰胺酶替换为欧文菌来源门冬酰胺酶。
- 关注年轻成人ALL患者特有的系统层面和心理社会障碍。
核心结论
- 通过更一致地应用儿童启发方案、优化门冬酰胺酶使用和以患者为中心的综合照护,改善年轻成人ALL患者结局。
研究设计与样本
- 本课程整合真实患者故事、当前证据、不断更新的指南推荐和专家临床经验,采用病例为基础的方法。
主要发现
- 课程提供门冬酰胺酶相关毒性的减轻、监测和管理结构化指导,并涉及影响年轻成人ALL患者的系统层面和心理社会障碍。
关键数值与推荐
- 实用推荐包括门冬酰胺酶活性的治疗性药物监测、临床和沉默性过敏反应的检测,以及免疫介导失活后及时将大肠杆菌来源门冬酰胺酶替换为欧文菌来源门冬酰胺酶以保持治疗活性和疗效。
临床怎么用
- 血液/肿瘤科医生可应用儿童启发方案、优化门冬酰胺酶使用、进行药物监测和过敏反应管理,并关注年轻成人患者的系统层面和心理社会障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This CME/CE integrates real patient stories, current evidence, evolving guideline recommendations, and expert clinical experience to equip hematology/oncology clinicians with practical strategies for successful asparaginase-based therapy in young adults with acute lymphoblastic leukemia (ALL). The overarching goal is to improve outcomes for young adults with ALL through more consistent application of pediatric-inspired regimens, optimized asparaginase use, and comprehensive, patient-centered care. Leukemia experts synthesize the latest evidence on the efficacy and safety of asparaginase-based ALL treatment for young adults. Using a case-based approach, the curriculum provides structured guidance on mitigation, monitoring, and management of key asparaginase-related toxicities. Practical recommendations include therapeutic drug monitoring of asparaginase activity, detection of clinical and silent hypersensitivity reactions, and timely substitution of Escherichia coli-derived asparaginase with Erwinia-derived asparaginase to preserve therapeutic activity and efficacy after immune-mediated inactivation. Beyond treatment selection and toxicity management, the activity addresses system-level and psychosocial barriers that uniquely affect young adults with ALL, such as distance from specialty centers, employment and family responsibilities, lower rates of clinical trial participation, and survivorship concerns. To view this activity, and obtain CME/CE credit, visit www.cmeologyce.org/ajh-all.
引用
- Cassaday RD, DeAngelo DJ. Patients First: Navigating Asparaginase-Based Treatment in Young Adults With Acute Lymphoblastic Leukemia. Am J Hematol. 2026. PMID: 41532388. doi:10.1002/ajh.70195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。